Wyle Laboratories said it isissuing in the Euro-Market 25 mln dlrs of 6-1/4 pct convertiblesubordinated debentures due March 2002.    The debentures are convertible into Wyle common stock at arate of 19.25 dlrs worth of debentures for each common share,the company said.    It said proceeds from the offering will be used for generalcorporate purposes, and to repay borrowings under the company'sbank credit line.    Kidder Peabody International Ltd and Montgomery Securitiesare co-managing the offering, Wyle also said. Reuter&#3;